Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jan 1;155(1):61-68.
doi: 10.1001/jamasurg.2019.4539.

Association of Postoperative Infection With Risk of Long-term Infection and Mortality

Affiliations
Observational Study

Association of Postoperative Infection With Risk of Long-term Infection and Mortality

William J O'Brien et al. JAMA Surg. .

Erratum in

  • Error in Figure.
    [No authors listed] [No authors listed] JAMA Surg. 2020 Jan 1;155(1):94. doi: 10.1001/jamasurg.2019.5520. JAMA Surg. 2020. PMID: 31940028 Free PMC article. No abstract available.

Abstract

Importance: Surgical site infection has been shown to decrease survival in veterans by up to 42%. The association of 30-day postoperative infections with long-term infections in the overall surgical population remains unknown.

Objective: To determine whether exposure to 30-day postoperative infection is associated with increased incidence of infection and mortality during postoperative days 31 to 365.

Design, setting, and participants: In this retrospective observational cohort study, veterans undergoing major surgery through the Veterans Health Administration from January 2008 to December 2015 were included. Stabilized inverse probability of treatment weighting was used to balance baseline characteristics of the control and exposure groups. Cox proportional hazards regression was used to estimate hazard ratios of long-term infection and mortality. Data were analyzed from September 2018 to May 2019.

Exposures: Any 30-day postoperative infection (exposure group) vs no 30-day infection (control group).

Main outcomes and measures: Number of days between index surgery and the occurrence of death or the patient's first infection during postoperative days 31 to 365. Patients who died before having a long-term infection were censored for the infection outcome.

Results: Of the 659 486 included patients, 604 534 (91.7%) were male, and the mean (SD) age was 59.7 (13.6) years. Among these patients, 23 815 (3.6%) had a 30-day infection, 43 796 (6.6%) had a long-term infection, and 24 810 (3.8%) died during follow-up. The most frequent 30-day infections were surgical site infection (9574 [40.2%]), urinary tract infection (6545 [27.5%]), pneumonia (3515 [14.8%]), and bloodstream infection (1906 [8.0%]). Long-term infection types included urinary tract infection (21 420 [48.7%]), skin and soft tissue infection (14 348 [32.6%]), bloodstream infection (3862 [8.8%]), and pneumonia (2543 [5.8%]). Patients in the exposure group had a higher observed incidence of long-term infection (5187 of 23 815 [21.8%]) and mortality (3067 of 23 815 [12.9%]) compared with those without 30-day infection (38 789 of 635 671 [6.1%] and 21 743 of 635 671 [3.4%], respectively). The estimated hazard ratio for long-term infection was 3.17 (95% CI, 3.05-3.28) and for mortality was 1.89 (95% CI, 1.79-1.99).

Conclusions and relevance: At any given point during the follow-up period, patients with 30-day postoperative infection had a 3.2-fold higher risk of 1-year infection and a 1.9-fold higher risk of mortality compared with those who had no 30-day infection. Cost-benefit calculations for surgical infection prevention programs should include the increased risk and costs of long-term infection and death. Preventive efforts in the first 30 days postoperatively may improve long-term patient outcomes.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Gupta has received personal fees for consulting from Iterum Therapeutics, Paratek Pharmaceuticals, Ocean Spray, and Tetraphase Pharmaceuticals; is an author for UpToDate; and has received investigator-initiated funding from the Veterans Affairs Health Services and Research Development Office on reducing postoperative infections. Dr Itani is a research consultant to Eupraxia Pharmaceuticals and has received an institutional grant from Sanofi. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. CONSORT Diagram
Figure 2.
Figure 2.. Frequency of Postoperative and Long-term Infection Types
BSI indicates bloodstream infection; SSI, surgical site infection; UTI, urinary tract infection.
Figure 3.
Figure 3.. Observed Cumulative Incidence of Infection and Mortality at 1 Year Stratified by Exposure to Infections and Bacteria Within 30 Days Postoperatively
BSI indicates bloodstream infection; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; SSI, surgical site infection; UTI, urinary tract infection.

Comment in

References

    1. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20(11):725-730. doi:10.1086/501572 - DOI - PubMed
    1. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol. 2004;25(6):461-467. doi:10.1086/502422 - DOI - PubMed
    1. Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. Ann Surg. 2010;252(6):1065-1071. doi:10.1097/SLA.0b013e3181dcf36e - DOI - PMC - PubMed
    1. Toner A, Hamilton M. The long-term effects of postoperative complications. Curr Opin Crit Care. 2013;19(4):364-368. doi:10.1097/MCC.0b013e3283632f77 - DOI - PubMed
    1. Toumpoulis IK, Anagnostopoulos CE, Derose JJ Jr, Swistel DG. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest. 2005;127(2):464-471. doi:10.1378/chest.127.2.464 - DOI - PubMed

Publication types